Cassava sciences inc (SAVA)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Program fee revenue

-

-

-

-

-

-

41,119

10,641

10,897

10,496

14,348

Collaboration revenue

-

-

-

-

-

-

-

249

587

1,313

6,215

Milestone revenue

-

-

-

-

-

-

-

-

-

5,000

-

Total revenue

-

-

-

-

-

-

41,119

10,890

11,484

16,809

20,563

Operating expenses:
Research and development, net of grant reimbursement

1,568

2,969

-

-

-

-

-

-

-

-

-

Research and development, net of grant reimbursement

-

-

7,615

9,176

9,100

7,306

4,917

7,605

8,300

15,746

21,059

General and administrative

3,391

3,693

4,334

5,781

5,102

5,127

4,837

7,182

6,698

14,766

6,258

Total operating expenses

4,959

6,662

11,949

14,957

14,202

12,433

9,754

14,787

14,998

30,512

27,317

Operating loss

-4,959

-6,662

-11,949

-14,957

-14,202

-12,433

31,365

-3,897

-3,514

-13,703

-6,754

Interest income

328

105

38

107

57

47

106

451

901

1,680

1,777

Income (loss) before provision for (benefit from) income taxes

-

-

-

-

-

-

31,471

-3,446

-2,613

-

-4,977

Provision for income taxes

-

-

-

-

-

-

-73

-

0

-

-1,510

Net loss

-4,631

-6,557

-11,911

-14,850

-14,145

-12,386

31,544

-3,446

-2,613

-12,023

-3,467

Basic

-

-

-

-

-

-

0.70

-0.08

-0.06

-

-

Diluted

-

-

-

-

-

-

0.70

-0.08

-0.06

-

-

Basic

-

-

-

-

-

-

45,007

44,753

44,160

-

-

Diluted

-

-

-

-

-

-

45,208

44,753

44,160

-

-

Net loss per share, basic and diluted

-0.27

-0.61

-1.82

-2.28

-0.31

-0.27

-

-

-

-0.28

-0.08

Shares used in computing net loss per share, basic and diluted

17,412

10,682

6,537

6,520

45,356

45,269

-

-

-

42

42,165